Latest news
Takeda scraps another phase 2 celiac disease therapy, narrowing pipeline to one - Fierce BiotechFierce Biotech · Thu, 30 Jul 2026 07:00:00 GMTEffects of Optimal Celiac Disease Management on Growth and Glycemic Outcomes in Children with Type 1 Diabetes — a Case-Control Study | Ruszkiewicz | Clinical Diabetology - Via Medica JournalsVia Medica Journals · Wed, 29 Jul 2026 11:05:22 GMT